The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments

Subjects

Out of stock

Price data checked 5 days ago

View at Amazon

One email. No newsletter. No nudges.

Sold out. We send one email the moment it's back. Last time, that took just a day or two.

Out of stock 5 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

This study covers the world outlook for rheumatoid arthritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of rheumatoid arthritis treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, F. Hoffman-La Roche, Johnson & Johnson, Pfizer, Sanofi, Sobi, and UCB. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZLX5DX7
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 04 May 2024

The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments

Sold out. We send one email the moment it's back. Last time, that took just a day or two.

Price History & Forecast

Price Distribution

Description

Product Specifications

Similar Products You Might Like

The 2026-2031 World Outlook for Rheumatoid Arthritis Treatments

The 2023-2028 Outlook for Rheumatoid Arthritis Treatments in China

The 2026-2031 World Outlook for Drugs for Rheumatoid Arthritis

The 2023-2028 Outlook for Rheumatoid Arthritis Treatments for US Zip Codes

Rheumatoid Arthritis: Methods and Protocols: 2766 (Methods in Molecular Biology, 2766)

Rheumatoid Arthritis - Treatment

Rheumatoid Arthritis: Other Perspectives towards a Better Practice

The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics

IntechOpen Rheumatoid Arthritis - Etiology and Consequences

The 2023-2028 Outlook for Psoriatic Arthritis Treatments in the United States

Textbook of Rheumatology: v. 2

Global Rheumatology, An Issue of Rheumatic Disease Clinics of North America (Volume 52-2) (The Clinics: Internal Medicine, Volume 52-2)

The 2023-2028 Outlook for Psoriatic Arthritis Treatments in China

Insights and Perspectives in Rheumatology

Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Encyclopedia of Rheumatoid Arthritis

Neyroimmunologicheskaya kharakteristika bol'nykh revmatoidnym artritom: Monografiya

Innovative Rheumatology

Challenges in Rheumatology

Psychosomatik, Radiologie, Immunologie, Pathologie, Klinik und Therapie Rheumatischer Erkrankungen: Vorträge des Kongresses der Deutschen Gesellschaft für Rheumatologie Regensburg, 28. September bis 2. Oktober 1976

The Giants of Rheumatology, An Issue of Rheumatic Disease Clinics of North America: Volume 50-1 (The Clinics: Internal Medicine, Volume 50-1)

The 2023-2028 World Outlook for Osteoarthritis Treatments

Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0